The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort

The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort

Background: Previous studies have shown that MCM3 plays a key role in initiating DNA replication. However, the mechanism of MCM3 function in most cancers is still unknown. The aim of our study was to explore the expression, prognostic role, and immunological characteristics of MCM3 across cancers.Me...

Full description

Bibliographic Details
Main Authors:	Qian-Rong Huang, Qian Jiang, Ju-Yuan Tan, Ren-Bao Nong, Jun Yan, Xia-Wei Yang, Li-Gen Mo, Guo-Yuan Ling, Teng Deng, Yi-Zhen Gong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Pharmacology
Subjects:	pan-cancer minichromosome maintenance complex component 3 (MCM3) immunotherapy prognosis lower-grade glioma
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1390615/full

Similar Items

The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids
by: Piotr Rubisz, et al.
Published: (2021-07-01)

Rac GTPase activating protein 1 promotes the glioma growth by regulating the expression of MCM3
by: Bo Jia, et al.
Published: (2023-11-01)

Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer
by: Büşra Köse, et al.
Published: (2023-06-01)

Correlation of Minichromosome Maintenance Protein 6 Expression Rate and Clinical Outcome in Patients With Hodgkin's Lymphoma
by: Kian Khodadad, et al.
Published: (2017-10-01)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
by: Qian-Rong Huang, et al.
Published: (2022-06-01)

Pan-Cancer Multi-Omics Analysis of Minichromosome Maintenance Proteins (MCMs) Expression in Human Cancers
by: Lulu Wang, et al.
Published: (2023-09-01)

MCM2 Expression in Different Molecular Subtypes of Epithelial Breast Cancers and its Association with Clinicopathological Parameters and Ki-67 Expression
by: MEGHADIPA MANDAL, et al.
Published: (2021-10-01)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
by: Wei Huang, et al.
Published: (2023-02-01)

Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer
by: Chen R, et al.
Published: (2022-06-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
by: Fahimeh Rezazadeh, et al.
Published: (2017-09-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
by: Shu Yang, et al.
Published: (2022-11-01)

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma
by: Yao Zhou, et al.
Published: (2023-12-01)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
by: Qingyun Zhu, et al.
Published: (2023-07-01)

Classification of diffuse lower‐grade glioma based on immunological profiling
by: Fan Wu, et al.
Published: (2020-09-01)

Expression and prognosis of GNG5 in lower-grade glioma using public database
by: Xiaohui Tan, et al.
Published: (2022-12-01)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
by: Huaide Qiu, et al.
Published: (2021-04-01)

Global RNA editome landscape discovers reduced RNA editing in glioma: loss of editing of gamma-amino butyric acid receptor alpha subunit 3 (GABRA3) favors glioma migration and invasion
by: Vikas Patil, et al.
Published: (2020-09-01)

Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
by: Yanxing Li, et al.
Published: (2024-03-01)

Immunological classification of gliomas based on immunogenomic profiling
by: Qiushi Feng, et al.
Published: (2020-11-01)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
by: Dong-Dong Yang, et al.
Published: (2020-02-01)

MCM7 Knockdown Inhibits Migration and Invasion While Induces Apoptosis of Cutaneous Malignant Melanoma Cells Through AKT Signaling Pathway
by: TANG Hua, et al.
Published: (2018-10-01)

Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma
by: Yunyang Zhu, et al.
Published: (2022-05-01)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
by: Shenglian Wu, et al.
Published: (2023-05-01)

Staged resection of multilobar lower-grade glioma: Case report and review of the literature
by: Ronald Sahyouni, et al.
Published: (2022-06-01)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
by: Li J, et al.
Published: (2021-10-01)

Preclinical modeling of lower-grade gliomas
by: Lilly W. Tang, et al.
Published: (2023-03-01)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
by: Agnieszka Pinkowska, et al.
Published: (2021-12-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
by: Xiaoshuai Ji, et al.
Published: (2020-10-01)

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
by: Wen-Jing Zeng, et al.
Published: (2018-05-01)

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
by: Mingyu Liu, et al.
Published: (2018-01-01)

DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas
by: Myung-Hoon Han, et al.
Published: (2023-05-01)

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response
by: Hongshu Zhou, et al.
Published: (2023-01-01)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
by: Jiayang Cai, et al.
Published: (2022-10-01)

A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes
by: Yusheng Shen, et al.
Published: (2022-05-01)

Comprehensive Analysis of the Prognostic Value and Immune Infiltration of Butyrophilin Subfamily 2/3 (BTN2/3) Members in Pan-Glioma
by: Dong He, et al.
Published: (2022-08-01)

Association of High Immunohistochemical Expression of Minichromosome Maintenance 3 with Human Oral Squamous Cell Carcinoma—A Preliminary Study
by: Rabia Zahir, et al.
Published: (2022-12-01)

Minichromosome maintenance 2 and 5 expressions are increased in the epithelium of hereditary gingival fibromatosis associated with dental abnormalities
by: Hercílio Martelli-Júnior, et al.
Published: (2011-01-01)

Pan-glioma analyses reveal species- and tumor-specific regulation of neuron-glioma synapse genes by lncRNAs
by: Wei Xiong, et al.
Published: (2023-08-01)

MCM10 expression is linked to cervical cancer aggressiveness
by: Sumayyah M. Q. Ahmed, et al.
Published: (2023-02-01)